In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Device company Veniti raises $25mm in Series D from Boston Scientific

Executive Summary

Veniti Inc. (devices for treatment of deep venous disease) raised $25mm in its Series D round from Boston Scientific Corp. The company will use the proceeds to complete its VIRTUS trial (using the Vici Venous Stent System to address chronic venous disorder, venous outflow obstruction, and symptomatic venous outflow obstruction of the iliofemoral vein); for a regulatory filing for the system; and to expand product development and commercial operations.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies